BIOTON S.A. (WSE:BIO)
4.000
+0.070 (1.78%)
At close: Dec 5, 2025
BIOTON Revenue
BIOTON had revenue of 72.65M PLN in the quarter ending September 30, 2025, with 73.06% growth. This brings the company's revenue in the last twelve months to 295.81M, up 66.56% year-over-year. In the year 2024, BIOTON had annual revenue of 207.76M with 14.38% growth.
Revenue (ttm)
295.81M
Revenue Growth
+66.56%
P/S Ratio
1.16
Revenue / Employee
814.91K
Employees
364
Market Cap
343.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
| Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
| Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
| Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
| Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |